Fed. Circ. Revives Leo Psoriasis Drug Patent
The Federal Circuit on Monday reversed a U.S. Patent and Trademark Office decision invalidating a Leo Pharmaceutical Products Ltd. patent for a psoriasis treatment, ruling the office ignored "compelling" evidence that...To view the full article, register now.
Already a subscriber? Click here to view full article